Journal of Virology, ISSN 0022-538X, 10/2011, Volume 85, Issue 20, pp. 10605 - 10616
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
NONHUMAN-PRIMATES | TYPE-1 GAG | RHABDOVIRUS | RESPIRATORY-TRACT | PROTEIN | VIROLOGY | HEMORRHAGIC-FEVER | VECTORED VACCINE | INFECTION | GLYCOPROTEIN | SAD B19 | Ebola Vaccines - genetics | Rabies - prevention & control | Hemorrhagic Fever, Ebola - prevention & control | Rabies Vaccines - administration & dosage | Virulence | Brain - virology | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Ebolavirus - immunology | Vaccines, Synthetic - adverse effects | Vaccines, Attenuated - administration & dosage | Ebola Vaccines - immunology | Rodent Diseases - prevention & control | Disease Models, Animal | Vaccines, Inactivated - genetics | Rabies virus - immunology | Vaccines, Synthetic - genetics | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Vaccines, Inactivated - adverse effects | Rabies Vaccines - immunology | Rabies virus - genetics | Vaccines, Attenuated - immunology | Vaccines, Inactivated - immunology | Animals | Vaccines, Inactivated - administration & dosage | Rabies Vaccines - adverse effects | Rabies Vaccines - genetics | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | Vaccines, Attenuated - adverse effects | Vaccines, Attenuated - genetics | Vaccines and Antiviral Agents
NONHUMAN-PRIMATES | TYPE-1 GAG | RHABDOVIRUS | RESPIRATORY-TRACT | PROTEIN | VIROLOGY | HEMORRHAGIC-FEVER | VECTORED VACCINE | INFECTION | GLYCOPROTEIN | SAD B19 | Ebola Vaccines - genetics | Rabies - prevention & control | Hemorrhagic Fever, Ebola - prevention & control | Rabies Vaccines - administration & dosage | Virulence | Brain - virology | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Ebolavirus - immunology | Vaccines, Synthetic - adverse effects | Vaccines, Attenuated - administration & dosage | Ebola Vaccines - immunology | Rodent Diseases - prevention & control | Disease Models, Animal | Vaccines, Inactivated - genetics | Rabies virus - immunology | Vaccines, Synthetic - genetics | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Vaccines, Inactivated - adverse effects | Rabies Vaccines - immunology | Rabies virus - genetics | Vaccines, Attenuated - immunology | Vaccines, Inactivated - immunology | Animals | Vaccines, Inactivated - administration & dosage | Rabies Vaccines - adverse effects | Rabies Vaccines - genetics | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | Vaccines, Attenuated - adverse effects | Vaccines, Attenuated - genetics | Vaccines and Antiviral Agents
Journal Article
PLoS neglected tropical diseases, ISSN 1935-2735, 10/2018, Volume 12, Issue 10, p. e0006870
Background Estimates of current global rabies mortality range from 26,000 to 59,000 deaths per annum. Although pre-exposure prophylaxis using inactivated...
IMMUNOGENICITY | VIRUS | ENHANCE | PROTECTION | FORMULATIONS | STABILITY | ANTIBODY | INDUCTION | CELL | PARASITOLOGY | TROPICAL MEDICINE | ADJUVANT | Rabies - prevention & control | Pre-Exposure Prophylaxis - methods | Adjuvants, Immunologic - administration & dosage | Costs and Cost Analysis | Rabies Vaccines - administration & dosage | Drug Stability | Vaccines, Synthetic - genetics | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Drug Carriers | Adenoviruses, Simian - genetics | Rabies Vaccines - immunology | Animals | Rabies Vaccines - economics | Rabies Vaccines - genetics | Female | Immunization Schedule | Mice | Vaccines, Synthetic - administration & dosage | Genetic Vectors | Vaccines, Synthetic - economics | Antibodies, Neutralizing - blood | Drugs | Rabies vaccines | Drug delivery systems | Pharmacology, Experimental | Microbial genetic engineering | Adenoviruses | Research | Vehicles | Climate | Laboratories | Prophylaxis | Antibodies | Viruses | Biology | Vaccines | Tropical diseases | Low cost | Tropical environment | Primates | Manufacturing | Children | Temperature distribution | Immunization | Mortality | Glycoprotein | Glycoproteins | Exposure | Disease control | Vectors (Biology) | Zoonoses | Organic chemistry | Immunogenicity | Programmes | Rabies | Financing | Cell lines | Serotypes | Fatalities
IMMUNOGENICITY | VIRUS | ENHANCE | PROTECTION | FORMULATIONS | STABILITY | ANTIBODY | INDUCTION | CELL | PARASITOLOGY | TROPICAL MEDICINE | ADJUVANT | Rabies - prevention & control | Pre-Exposure Prophylaxis - methods | Adjuvants, Immunologic - administration & dosage | Costs and Cost Analysis | Rabies Vaccines - administration & dosage | Drug Stability | Vaccines, Synthetic - genetics | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Drug Carriers | Adenoviruses, Simian - genetics | Rabies Vaccines - immunology | Animals | Rabies Vaccines - economics | Rabies Vaccines - genetics | Female | Immunization Schedule | Mice | Vaccines, Synthetic - administration & dosage | Genetic Vectors | Vaccines, Synthetic - economics | Antibodies, Neutralizing - blood | Drugs | Rabies vaccines | Drug delivery systems | Pharmacology, Experimental | Microbial genetic engineering | Adenoviruses | Research | Vehicles | Climate | Laboratories | Prophylaxis | Antibodies | Viruses | Biology | Vaccines | Tropical diseases | Low cost | Tropical environment | Primates | Manufacturing | Children | Temperature distribution | Immunization | Mortality | Glycoprotein | Glycoproteins | Exposure | Disease control | Vectors (Biology) | Zoonoses | Organic chemistry | Immunogenicity | Programmes | Rabies | Financing | Cell lines | Serotypes | Fatalities
Journal Article
Equine Veterinary Journal, ISSN 0425-1644, 11/2019, Volume 51, Issue 6, pp. 774 - 778
Summary Background Potomac horse fever (PHF) is a potentially fatal enterocolitis of horses caused by Neorickettsia risticii. The disease was originally...
horse | multivalent vaccine | equine neorickettsiosis | Potomac horse fever | monovalent vaccine | Neorickettsia risticii | Experimental and Basic Research Studies | General
horse | multivalent vaccine | equine neorickettsiosis | Potomac horse fever | monovalent vaccine | Neorickettsia risticii | Experimental and Basic Research Studies | General
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 07/2016, Volume 10, Issue 7, p. e0004846
Background In 1980, human diploid cell vaccine (HDCV, Imovax Rabies, Sanofi Pasteur), was licensed for use in the United States. Objective To assess adverse...
IMMUNIZATION | COLLECTION | ADVISORY-COMMITTEE | RECOMMENDATIONS | ACUTE DISSEMINATED ENCEPHALOMYELITIS | GUILLAIN-BARRE-SYNDROME | GUIDELINES | RISK | PARASITOLOGY | TROPICAL MEDICINE | Product Surveillance, Postmarketing - statistics & numerical data | United States - epidemiology | Adverse Drug Reaction Reporting Systems | Humans | Rabies Vaccines - adverse effects | Cell Culture Techniques - methods | Drug-Related Side Effects and Adverse Reactions - epidemiology | Prevention | Rabies vaccines | Rabies | Analysis | Medical records | Research | Health aspects | Studies | Medical research | Vaccines
IMMUNIZATION | COLLECTION | ADVISORY-COMMITTEE | RECOMMENDATIONS | ACUTE DISSEMINATED ENCEPHALOMYELITIS | GUILLAIN-BARRE-SYNDROME | GUIDELINES | RISK | PARASITOLOGY | TROPICAL MEDICINE | Product Surveillance, Postmarketing - statistics & numerical data | United States - epidemiology | Adverse Drug Reaction Reporting Systems | Humans | Rabies Vaccines - adverse effects | Cell Culture Techniques - methods | Drug-Related Side Effects and Adverse Reactions - epidemiology | Prevention | Rabies vaccines | Rabies | Analysis | Medical records | Research | Health aspects | Studies | Medical research | Vaccines
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 50, pp. 5940 - 5947
Highlights • Sanofi Pasteur has developed a next-generation rabies vaccine (PVRV-NG). • PVRV-NG is an evolution of Sanofi Pasteur's currently licensed rabies...
Allergy and Immunology | Clinical trial | Post-exposure prophylaxis | Rabies vaccine | Safety | Immunogenicity | Rabies | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGY | Rabies - prevention & control | Rabies Vaccines - administration & dosage | Humans | Middle Aged | Culture Media, Serum-Free | Male | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | China | Rabies Vaccines - isolation & purification | Aged, 80 and over | Adult | Female | Child | Vero Cells | Post-Exposure Prophylaxis - methods | Technology, Pharmaceutical - methods | Drug-Related Side Effects and Adverse Reactions - epidemiology | Rabies Vaccines - immunology | Animals | Rabies Vaccines - adverse effects | Adolescent | Aged | Antibodies, Neutralizing - blood | Immunization | Vaccines | Mortality | Public health
Allergy and Immunology | Clinical trial | Post-exposure prophylaxis | Rabies vaccine | Safety | Immunogenicity | Rabies | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGY | Rabies - prevention & control | Rabies Vaccines - administration & dosage | Humans | Middle Aged | Culture Media, Serum-Free | Male | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | China | Rabies Vaccines - isolation & purification | Aged, 80 and over | Adult | Female | Child | Vero Cells | Post-Exposure Prophylaxis - methods | Technology, Pharmaceutical - methods | Drug-Related Side Effects and Adverse Reactions - epidemiology | Rabies Vaccines - immunology | Animals | Rabies Vaccines - adverse effects | Adolescent | Aged | Antibodies, Neutralizing - blood | Immunization | Vaccines | Mortality | Public health
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 09/2012, Volume 169, Issue 3, pp. 199 - 204
Summary The development of vaccines that prevent rabies has a long and distinguished history, with the earliest preceding modern understanding of viruses and...
rabies virus | reverse genetics | central nervous system | vaccination | Rabies virus | Vaccination | Central nervous system | Reverse genetics | VIRUS GLYCOPROTEIN | STAT1 | ANTIBODY | IMMUNOLOGY | RESPONSES | IMMUNOGENICITY | RECOMBINANT | GROWTH | MICE | Rabies - prevention & control | Chiroptera - virology | Humans | Vaccines, Inactivated | Rabies - immunology | Vaccination - veterinary | Endemic Diseases | Bites and Stings - virology | Nervous System - pathology | Rabies - virology | Rabies Vaccines - classification | Vaccination - trends | Models, Animal | Disease Reservoirs | Dog Diseases - prevention & control | Dog Diseases - virology | Antibodies, Viral - biosynthesis | Genome, Viral | Rabies virus - physiology | Rabies virus - immunology | Global Health | Immunity, Innate | Rabies - pathology | Rabies Vaccines - immunology | Rabies virus - genetics | Animals | Dogs - virology | Rabies - epidemiology | Vaccines, Synthetic | Antibodies, Viral - immunology | Mice | Nervous System - virology | Rabies - transmission | Disease transmission | Vaccines | Health aspects | Rabies | Zoonoses | Viruses | Immune system | Infection | Antiviral agents | Inoculation | Immune response | Wildlife | Prophylaxis | Livestock | Review
rabies virus | reverse genetics | central nervous system | vaccination | Rabies virus | Vaccination | Central nervous system | Reverse genetics | VIRUS GLYCOPROTEIN | STAT1 | ANTIBODY | IMMUNOLOGY | RESPONSES | IMMUNOGENICITY | RECOMBINANT | GROWTH | MICE | Rabies - prevention & control | Chiroptera - virology | Humans | Vaccines, Inactivated | Rabies - immunology | Vaccination - veterinary | Endemic Diseases | Bites and Stings - virology | Nervous System - pathology | Rabies - virology | Rabies Vaccines - classification | Vaccination - trends | Models, Animal | Disease Reservoirs | Dog Diseases - prevention & control | Dog Diseases - virology | Antibodies, Viral - biosynthesis | Genome, Viral | Rabies virus - physiology | Rabies virus - immunology | Global Health | Immunity, Innate | Rabies - pathology | Rabies Vaccines - immunology | Rabies virus - genetics | Animals | Dogs - virology | Rabies - epidemiology | Vaccines, Synthetic | Antibodies, Viral - immunology | Mice | Nervous System - virology | Rabies - transmission | Disease transmission | Vaccines | Health aspects | Rabies | Zoonoses | Viruses | Immune system | Infection | Antiviral agents | Inoculation | Immune response | Wildlife | Prophylaxis | Livestock | Review
Journal Article
Journal of Virology, ISSN 0022-538X, 2015, Volume 89, Issue 1, pp. 144 - 154
The emerging zoonotic pathogens Hendra virus (HeV) and Nipah virus (NiV) are in the genus Henipavirus in the family Paramyxoviridae. HeV and NiV infections can...
NEUTRALIZING ANTIBODIES | VIROLOGY | HENDRA-VIRUS | PROTECTION | SARS-COV | G-GLYCOPROTEIN | NIPAH-VIRUS | VESICULAR STOMATITIS-VIRUS | MONOCLONAL-ANTIBODIES | ENVELOPE PROTEINS | RECOMBINANT RABIES VIRUS | Viral Vaccines - genetics | Drug Carriers - administration & dosage | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Hendra Virus - immunology | Henipavirus Infections - prevention & control | Vaccination - methods | Drug-Related Side Effects and Adverse Reactions | Vaccines, Attenuated - administration & dosage | Vesiculovirus - genetics | Vaccines, Inactivated - genetics | Viral Envelope Proteins - genetics | Henipavirus Infections - immunology | Vaccines, Synthetic - genetics | Injections, Intramuscular | Administration, Intranasal | Viral Vaccines - administration & dosage | Rabies virus - genetics | Vaccines, Attenuated - immunology | Vaccines, Inactivated - immunology | Animals | Vaccines, Inactivated - administration & dosage | Viral Envelope Proteins - immunology | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | Genetic Vectors | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Hendra Virus - genetics | Vaccines, Attenuated - genetics
NEUTRALIZING ANTIBODIES | VIROLOGY | HENDRA-VIRUS | PROTECTION | SARS-COV | G-GLYCOPROTEIN | NIPAH-VIRUS | VESICULAR STOMATITIS-VIRUS | MONOCLONAL-ANTIBODIES | ENVELOPE PROTEINS | RECOMBINANT RABIES VIRUS | Viral Vaccines - genetics | Drug Carriers - administration & dosage | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Hendra Virus - immunology | Henipavirus Infections - prevention & control | Vaccination - methods | Drug-Related Side Effects and Adverse Reactions | Vaccines, Attenuated - administration & dosage | Vesiculovirus - genetics | Vaccines, Inactivated - genetics | Viral Envelope Proteins - genetics | Henipavirus Infections - immunology | Vaccines, Synthetic - genetics | Injections, Intramuscular | Administration, Intranasal | Viral Vaccines - administration & dosage | Rabies virus - genetics | Vaccines, Attenuated - immunology | Vaccines, Inactivated - immunology | Animals | Vaccines, Inactivated - administration & dosage | Viral Envelope Proteins - immunology | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | Genetic Vectors | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Hendra Virus - genetics | Vaccines, Attenuated - genetics
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 41, pp. 5021 - 5025
Highlights • A vaccine-induced case of rabies was detected in a cow in Romania. • Vaccine producers are now able to detect any variants of their master seed...
Allergy and Immunology | Pathogenicity | Vaccine | Sequencing | SAD B19 | Rabies | Fox | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS-VACCINE | ASSAY | IMMUNOLOGY | EUROPE | ORAL VACCINATION | WILDLIFE | VULPES-VULPES | Rabies virus - isolation & purification | Cattle - virology | Rabies - chemically induced | Rabies virus - genetics | Animals | Romania | Rabies Vaccines - adverse effects | Brain - virology | Phylogeny | RNA, Viral - isolation & purification | Vaccines, Attenuated - adverse effects | Brain | Disease transmission | Vaccines | Analysis | Vaccination | Reservoirs | Target marketing | Zoonoses | Immunization | Foxes
Allergy and Immunology | Pathogenicity | Vaccine | Sequencing | SAD B19 | Rabies | Fox | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS-VACCINE | ASSAY | IMMUNOLOGY | EUROPE | ORAL VACCINATION | WILDLIFE | VULPES-VULPES | Rabies virus - isolation & purification | Cattle - virology | Rabies - chemically induced | Rabies virus - genetics | Animals | Romania | Rabies Vaccines - adverse effects | Brain - virology | Phylogeny | RNA, Viral - isolation & purification | Vaccines, Attenuated - adverse effects | Brain | Disease transmission | Vaccines | Analysis | Vaccination | Reservoirs | Target marketing | Zoonoses | Immunization | Foxes
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 43, pp. 5829 - 5837
Abstract Background Vaccines are the most effective prophylactic public health tools. With the help of vaccines, prevention of infectious disease spread and,...
Allergy and Immunology | Population distance | Deep sequencing | Live-attenuated vaccines | Vaccine quality control | Viral population analysis | MEDICINE, RESEARCH & EXPERIMENTAL | ELIMINATION | IMMUNOLOGY | ACCURACY | EUROPE | RED FOXES | ORAL IMMUNIZATION | ALIGNMENT | RNA VIRUS EVOLUTION | MUTATION | WILDLIFE | RABIES VIRUS | Genomic Instability | Humans | Technology, Pharmaceutical - methods | Rabies Vaccines - standards | Genetic Variation | Rabies virus - genetics | Genetics, Population - methods | RNA, Viral - genetics | Rabies Vaccines - genetics | Vaccines, Attenuated - standards | Sequence Analysis, DNA - methods | Quality Control | Vaccines, Attenuated - genetics | Analysis | Genomics | Quality control | Genetic research | Genomes | Vaccines | Cells | Quality management | Studies | Medical research | Genealogy | Laboratories | Rabies | Viruses | Population
Allergy and Immunology | Population distance | Deep sequencing | Live-attenuated vaccines | Vaccine quality control | Viral population analysis | MEDICINE, RESEARCH & EXPERIMENTAL | ELIMINATION | IMMUNOLOGY | ACCURACY | EUROPE | RED FOXES | ORAL IMMUNIZATION | ALIGNMENT | RNA VIRUS EVOLUTION | MUTATION | WILDLIFE | RABIES VIRUS | Genomic Instability | Humans | Technology, Pharmaceutical - methods | Rabies Vaccines - standards | Genetic Variation | Rabies virus - genetics | Genetics, Population - methods | RNA, Viral - genetics | Rabies Vaccines - genetics | Vaccines, Attenuated - standards | Sequence Analysis, DNA - methods | Quality Control | Vaccines, Attenuated - genetics | Analysis | Genomics | Quality control | Genetic research | Genomes | Vaccines | Cells | Quality management | Studies | Medical research | Genealogy | Laboratories | Rabies | Viruses | Population
Journal Article
Vaccine, ISSN 0264-410X, 09/2018, Volume 36, Issue 37, pp. 5500 - 5503
This article presented the World Health Organization's (WHO) recommendations on the use of Rabies vaccines excerpted from the Rabies vaccines: WHO position...
Position paper | Recommendations | Immunoglobulins | Vaccines | Rabies | WHO | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGY | Immunization Programs - statistics & numerical data | Rabies - prevention & control | Public Health | World Health Organization | Post-Exposure Prophylaxis - standards | Rabies - therapy | Humans | Immunization - standards | Rabies Vaccines - adverse effects | Rabies Vaccines - therapeutic use | Immunization Programs - organization & administration | Health Policy | Water-borne diseases | Evaluation | Schedules | Immunization | Meetings | Vaccination | Prophylaxis | Feasibility studies | Exposure | Infections | Patients | Epidemiology | Cost control | Health policy | Surveillance | Cholera | Quality assessment | Public health | Age groups
Position paper | Recommendations | Immunoglobulins | Vaccines | Rabies | WHO | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGY | Immunization Programs - statistics & numerical data | Rabies - prevention & control | Public Health | World Health Organization | Post-Exposure Prophylaxis - standards | Rabies - therapy | Humans | Immunization - standards | Rabies Vaccines - adverse effects | Rabies Vaccines - therapeutic use | Immunization Programs - organization & administration | Health Policy | Water-borne diseases | Evaluation | Schedules | Immunization | Meetings | Vaccination | Prophylaxis | Feasibility studies | Exposure | Infections | Patients | Epidemiology | Cost control | Health policy | Surveillance | Cholera | Quality assessment | Public health | Age groups
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 44, pp. 5352 - 5358
Abstract Bats (Order Chiroptera) are an abundant group of mammals with tremendous ecological value as insectivores and plant dispersers, but their role as...
Allergy and Immunology | Vaccine | Poxvirus | Bat | Rabies | Chiroptera | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS GLYCOPROTEIN | PUBLIC-HEALTH | PROTECTION | RECOMBINANT VACCINE | IMMUNOLOGY | IMMUNIZATION | TRANSMISSION | DESMODUS-ROTUNDUS | ORAL VACCINATION | PROCYON-LOTOR | VAMPIRE BATS | Immunogenicity, Vaccine | Rabies - prevention & control | Chiroptera - virology | Chiroptera - immunology | Rabies Vaccines - administration & dosage | Male | Luminescent Measurements | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Vaccinia virus - genetics | Vaccinia virus - isolation & purification | Vaccinia virus - immunology | Luciferases - genetics | Rabies - veterinary | Vaccination - methods | Mouth - virology | Poxviridae - isolation & purification | Vaccines, Attenuated - administration & dosage | Orthopoxvirus - genetics | Orthopoxvirus - physiology | Poxviridae - physiology | Rabies virus - immunology | Poxviridae - immunology | Rabies Vaccines - immunology | Vaccines, Attenuated - immunology | Animals | Virus Replication | Rabies Vaccines - genetics | Genetic Vectors | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Vaccines, Attenuated - genetics | Vaccinia virus - physiology | Virus diseases | Bats | Genetic vectors | Vaccines | Health aspects | Zoonoses | Luciferase | Viruses
Allergy and Immunology | Vaccine | Poxvirus | Bat | Rabies | Chiroptera | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS GLYCOPROTEIN | PUBLIC-HEALTH | PROTECTION | RECOMBINANT VACCINE | IMMUNOLOGY | IMMUNIZATION | TRANSMISSION | DESMODUS-ROTUNDUS | ORAL VACCINATION | PROCYON-LOTOR | VAMPIRE BATS | Immunogenicity, Vaccine | Rabies - prevention & control | Chiroptera - virology | Chiroptera - immunology | Rabies Vaccines - administration & dosage | Male | Luminescent Measurements | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Vaccinia virus - genetics | Vaccinia virus - isolation & purification | Vaccinia virus - immunology | Luciferases - genetics | Rabies - veterinary | Vaccination - methods | Mouth - virology | Poxviridae - isolation & purification | Vaccines, Attenuated - administration & dosage | Orthopoxvirus - genetics | Orthopoxvirus - physiology | Poxviridae - physiology | Rabies virus - immunology | Poxviridae - immunology | Rabies Vaccines - immunology | Vaccines, Attenuated - immunology | Animals | Virus Replication | Rabies Vaccines - genetics | Genetic Vectors | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Vaccines, Attenuated - genetics | Vaccinia virus - physiology | Virus diseases | Bats | Genetic vectors | Vaccines | Health aspects | Zoonoses | Luciferase | Viruses
Journal Article